Meropenem Dosing in ICU Patients with Normal Renal Function

Standard Dosing Recommendations

Higher daily doses of beta-lactam antibiotics, including meropenem, should be used at the onset of treatment in critically ill patients with preserved renal function, as recommended by the Critical Care society 1, 2

ICU patients often have altered pharmacokinetics of beta-lactams, including meropenem, due to increased clearance in patients with preserved renal function, and tissue hypoperfusion due to shock and/or vasoconstrictors, according to the Critical Care society 2, 3

Continuous infusion of meropenem may be used, but requires consideration of the drug's limited stability at room temperature, as noted by the Critical Care society 1

TDM is recommended in ICU patients with clinical signs of potential toxicity, as suggested by the Critical Care society 1, 2
Neurological toxicity can occur with excessive plasma concentrations of meropenem, with a trough concentration greater than 64 mg/L, as reported by the Critical Care society 3

Meropenem has a relatively low pro-convulsive activity compared to other beta-lactams, but neurological adverse effects may occur when plasma concentrations exceed 64 mg/L, according to the Critical Care society 3
When the free trough concentration normalized to the EUCAST clinical breakpoint for Pseudomonas aeruginosa exceeds 8, neurological deterioration may occur in approximately two-thirds of ICU patients, as found by the Critical Care society 3

Underdosing is common in ICU patients with normal renal function due to increased clearance and volume of distribution, as noted by the Critical Care society 2
Continuous infusion requires consideration of drug stability, with a duration of 6-12 hours at room temperature, as reported by the Critical Care society 1

For severe infections including bloodstream infections with carbapenem-resistant Enterobacterales, the Infectious Diseases Society of America recommends 1 gram every 8 hours by extended infusion 4

The Society of Critical Care Medicine suggests that extended infusion of meropenem for 3 hours is beneficial for optimizing pharmacokinetic/pharmacodynamic properties when treating resistant organisms with higher MICs 5

For treatment of multidrug-resistant infections, the European Society of Clinical Microbiology and Infectious Diseases recommends extended infusion of meropenem for 3 hours if the meropenem MIC is ≥ 8 mg/L 4
In critically ill patients with intra-abdominal infections, the World Society of Emergency Surgery recommends 1 gram every 8 hours 6
When used as part of polymyxin-based combination therapy for carbapenem-resistant infections, the Infectious Diseases Society of America recommends 1 gram every 8 hours by extended infusion 4

The Critical Care society recommends therapeutic drug monitoring (TDM) for patients undergoing renal replacement therapy, and for ICU patients with expected pharmacokinetic variability or clinical signs of toxicity 7
TDM should be performed to maintain target plasma concentration above the MIC of the suspected pathogen, with monitoring for potential neurological adverse effects (seizures) with excessive plasma concentrations, particularly in patients with CNS infections or severe renal impairment 7
Continuous infusion may be used but requires consideration of meropenem's limited stability at room temperature, typically requiring preparation of new infusion bags every 6 hours 7

For carbapenem-resistant Enterobacterales (CRE) bloodstream infections, the recommended dosage is 1 gram IV every 8 hours by extended infusion (3 hours) 8, 9

The treatment duration for bloodstream infections is 7-14 days, for complicated urinary tract infections is 5-7 days, and for complicated intra-abdominal infections is 5-7 days, with individualization according to infection site, source control, underlying comorbidities, and initial response to therapy 8, 9

For hospital-acquired pneumonia or ventilator-associated pneumonia, the recommended dosage is 1 gram IV every 8 hours 10, 11
For polymyxin-based combinations in carbapenem-resistant infections, Meropenem 1 gram IV every 8 hours by extended infusion is recommended 8, 9